ArticleScientific reports2026
A multipurpose 1DZnO nanoplatform to combat ampicillin-resistant E. coli.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nanomaterials can provide versatile alternatives for accurate biodetection and treatment to prevent the rapid propagation of antimicrobial-resistant (AMR) microorganisms. Nevertheless, a characterization of their global effects must be conducted before management and experimental use, particularly for in vivo applications. In this work, we evaluated the multifunctional properties of one-dimensional ZnO nanowires (ZnO NWs) for optical biodetection of ampicillin-resistant Escherichia coli (ampr-E. coli). In addition, we assessed the antibacterial effects against these bacteria and biocompatibility after interaction with mammalian cells, providing new insights into the novel functionalities of ZnO NWs. From our experimental design, we obtained quenching of photoluminescence (PL) after 10 s of contact with biofunctionalized ZnO NWs across bacterial concentrations of 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.